From: Becker's Spine Review <>
Subject: Medtronic-Covidien deal sets new medical dev. co. precedent-10 trends on transactions | Amedica closes $13M IPO-5 things to know | What is Stryker responsible for in the OtisMed settlement?
Tex View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+

Dec. 11, 2014
Special Edition: Device Company Updates & Trends
1. 10 big trends in medical device company transactions Full story    

2. Free Webinar: Make Patients Feel More Comfortable After Outpatient Spine and Orthopedic Surgery: What's New in Pain Management. Click here to learn more and register.
3. 5 key thoughts on medical device companies - Who to watch for & who to pass over Full story
4. 5 key concepts on Amedica's $13M IPO close Full story

5. 6 points on FDA panel physicians...and their payments from device companies Full story

6. What is Stryker responsible for in the OtisMed settlement? 5 things to know 
Full story 


7. What is the latest piece of technology you acquired? Why did you decide to acquire it? If you'd like to contribute to this article, contact Anuja Vaidya at by Dec. 10. 

8. FTC, EU approve Medtronic's acquisition of Covidien - 8 things to know Full story 


9. What happens when data links device company payments with physician decisions? Full story

10. Flower Orthopedics raises $2.2M in private sale Full story
11. 50 things to know about spine device markets - What to expect in the next 5 years Full story  


Join Our Mailing List
Contact Us

Editorial Contact: 
Laura Dyrda
(800) 417-2035
email editorial

Sales, Marketing & Events:
Jessica Cole
President and CEO
Becker's Spine Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601

Copyright 2014. All Rights Reserved.

Forward this email

This email was sent to by |  

Becker's Spine Review | 35 E. Wacker Dr. #1782 | Chicago | IL | 60601